Main Page Side Effects Insurance Coverage Review Board

Does Blue Cross Blue Shield Tennessee Cover Mounjaro for Weight Loss?

Does Blue Cross Blue Shield Tennessee Cover Mounjaro? Tennessee BCBS Coverage Guide 2026

Tennessee-based patients wondering whether your Blue Cross Blue Shield plan covers Mounjaro, coverage varies based on several key factors. BlueCross BlueShield of Tennessee manages coverage for hundreds of thousands of Tennessee residents, and the formulary treatment of Mounjaro (the dual GIP/GLP-1 receptor agonist) differs from other state BCBS affiliates.


BCBS Tennessee Formulary Status for Mounjaro

BlueCross BlueShield of Tennessee maintains a drug list that can diverge from other Blue Cross affiliates. In the current plan year, Mounjaro is generally listed at Tier 4 (non-preferred specialty brand) on most BlueCross BlueShield of Tennessee commercial plans.

This means:

  • Prior authorization is required for all plans
  • Step therapy is often required — requiring trial of formulary-preferred drugs first
  • Out-of-pocket costs usually land between $50–$150/month depending on your specific plan tier
  • Some Tennessee employer-sponsored BCBS plans may cover Mounjaro at a better tier

At retail price, Mounjaro costs $1,000–$1,200 per month in Nashville and across Tennessee.


Mounjaro Coverage for Diabetes vs. Weight Loss in Tennessee

BlueCross BlueShield of Tennessee’s coverage rules for Mounjaro are shaped by the reason for prescribing.

For type 2 diabetes (FDA-approved indication):

  • Approval is more straightforward
  • The majority of Tennessee BCBS plans authorize Mounjaro when medical necessity is demonstrated
  • What you need typically includes failed prior therapy documentation

For weight loss (off-label for some formulations):

  • BlueCross BlueShield of Tennessee applies stricter criteria
  • Documentation must prove BMI ≥30 (or ≥27 and a weight-related comorbidity)
  • Many Tennessee plans don’t cover anti-obesity medications entirely

How to Get Mounjaro Approved by Your Tennessee Blue Cross Plan

Getting authorization for Mounjaro with BlueCross BlueShield of Tennessee involves a strategic approach.

  1. Confirm your plan’s formulary — Log into your BlueCross BlueShield of Tennessee member portal to verify Mounjaro’s coverage status for your benefit design
  2. Coordinate with your prescriber submit prior authorization — Include supporting medical records
  3. Demonstrate unsuccessful prior therapies — BCBS Tennessee’s rules often requires evidence of trying at least two other medications first
  4. Appeal if denied — BlueCross BlueShield of Tennessee offers multiple appeal stages plus external review through

According to industry data that approximately 30% of GLP-1 prior authorization requests are initially denied but over 60% win on appeal.


Alternatives if BCBS Tennessee Denies Coverage

If BlueCross BlueShield of Tennessee won’t approve Mounjaro coverage, explore these alternatives:

  • Manufacturer savings programs — Eli Lilly has savings cards that can reduce costs to significantly less for eligible non-government plan patients
  • Compounding pharmacy options — Accessible from Tennessee-licensed pharmacies at lower prices, though insurance rarely covers this
  • Consider formulary-preferred drugs — BlueCross BlueShield of Tennessee might cover at a lower tier an alternative in the same class
  • Tennessee state pharmaceutical assistance programs — Look into Tennessee offers any state-run prescription assistance for high-cost medications

Bottom Line for Tennessee BCBS Members

BlueCross BlueShield of Tennessee does cover Mounjaro — the path to coverage is not automatic and depends on prior authorization, step therapy documentation, and medical necessity. Start by checking your specific formulary and working with your provider to build the strongest possible case.

References

  1. FDA Prescribing Information for GLP-1 receptor agonists. U.S. Food and Drug Administration. 2024.
  2. SURPASS and SURMOUNT clinical trial programs. Eli Lilly and Company. 2022-2025.
  3. SUSTAIN and STEP clinical trial programs. Novo Nordisk. 2017-2024.
  4. American Diabetes Association Standards of Care in Diabetes. 2025.
  5. American Society of Health-System Pharmacists (ASHP) Drug Information. 2025.